NCT05733000
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
Clinical trial condition
Refractory Colorectal Carcinoma
Explore clinical trials studying Refractory Colorectal Carcinoma. Study availability and eligibility vary by location and protocol.
8 public trials
1 recruiting study
Refractory Colorectal Carcinoma trial results
NCT03436563
- Conditions
- Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +27 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03800602
- Conditions
- Colonic Diseases, Colorectal Adenocarcinoma, Colorectal Cancer Metastatic, +16 more
- Locations
-
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States
NCT02873195
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +14 more
- Locations
-
- Mayo Clinic Hospital Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
Active, Not Recruiting
Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer
NCT03844620
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +17 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
NCT02595931
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Colonic Diseases, +42 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- Keck Medical Center of USC Pasadena Pasadena, California, United States
Active, Not Recruiting
Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer
NCT02983578
- Conditions
- Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
NCT04294264
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +15 more
- Locations
-
- Trinitas Hospital and Comprehensive Cancer Center Elizabeth, New Jersey, United States
- RWJBarnabas Health - Monmouth Medical Center Southern Campus Lakewood, New Jersey, United States
- Saint Barnabas Medical Center Livingston, New Jersey, United States
- RWJBarnabas Health - Monmouth Medical Center Long Branch, New Jersey, United States